| 
        
         
 
      Spring 2002 (10.1) 
      Page
      17 
       
      Studying Alzheimer's Disease 
 
        Dr. Gumrah Aliyev, medical researcher at Case Western Reserve University
      School of Medicine in Cleveland, Ohio, USA, has recently been
      awarded two major grants for funding study on Alzheimer's disease.
      The first grant, from the U.S. Presidential New Technology Development
      Grant Foundation, provides $50,000 each year for direct research;
      the second, from the Philip Morris External Research Program,
      is a three-year research grant for $680,000. Aliyev [whose name
      is sometimes spelled through Russian as Gjumrakch Aliev] is an
      Azerbaijani from Nakhchivan and holds an M.D. from the Baku Medical
      Institute (cum laude, 1982) as well as a Ph.D. and Doctor of
      Sciences degree from the Russian Academy of Sciences and the
      University College of London (1989, 1995). He currently co-directs
      the Microscopy Research Center at Case Western Reserve University,
      School of Medicine, which focuses on the study of cardiovascular
      and cerebrovascular diseases as well as tumors and especially
      the role of brain blood flow and metabolism. 
 
      Dr. Gumrah Aliyev 
 
      Alzheimer's disease is a progressive neuro-degenerative disease
      that affects millions of people worldwide, 4 million of these
      just in the United States. According to the Alzheimer's Association,
      by 2025, an estimated 22 million people worldwide will have Alzheimer's.
      Patients with this disease suffer from memory loss, disorientation,
      confusion, mood swings and even changes in personality. The disease
      is difficult for doctors to diagnose, as they have to first eliminate
      all other possible causes or disorders that could be causing
      the dementia. As yet, there is no cure for Alzheimer's. 
 
      Dr. Aliyev's goal is to find out how to diagnose Alzheimer's
      disease in its earlier stages. With an early diagnosis, Alzheimer's
      patients would have time to plan for the future and could begin
      treatment sooner to try to slow the effects of the disease.  
 
      Both grants will support his ongoing research, which uses genetically
      engineered mice as a model for studying Alzheimer's in humans.
      Specifically, he is studying the development of Alzheimer's disease
      in mice that are exposed to hypoxia [oxygen deficiency], thereby
      mimicking the effects of smoking on humans. "I'm looking
      at Alzheimer's disease as a vascular disease with neurological
      consequences," Aliyev says. "I want to find out how
      smoking affects the development of cerebrovascular diseases,
      and therefore Alzheimer's disease and cardiovascular diseases
      in general." 
 
      Another major part of the grant will go toward the study of the
      possible protective effect of natural antioxidants such as a
      flavonoid derivative - namely Morin hydrate, which is derived
      from a plant in the Brazilian rain forest. This antioxidant may
      block or at least delay the development of Alzheimer's, Aliyev
      says. 
 
      He has authored more than 250 articles, including a recent article
      on Alzheimer's disease that has been considered one of the top
      studies worldwide in the Alzheimer's research field; this article
      was published in the January 2002 issue of "Brain Pathology."
      He is an editorial board member for three medical journals: "Journal
      of Submicroscopic Cytology and Pathology," "Journal
      of Alzheimer's Disease" and "Histology and Histopathology."
      He will also be featured in the upcoming 2002 edition of "Who's
      Who in Medicine and Healthcare." 
 
      One day, Aliyev hopes to set up a special Aging Research Center
      in Azerbaijan. He believes that cardiovascular, cerebrovascular
      and neurodegenerative diseases all have a common background and
      therefore can be treated in similar ways. Moreover, since genetic
      factors are directly related to the onset of Alzheimer's and
      cardiovascular diseases, Azerbaijan's population - with its traditional
      tendency toward intermarriage between close relatives - is at
      high risk for the disease. Unfortunately, there has not yet been
      any study or focus on preventing these diseases in Azerbaijan. 
       
      ____ 
      Back to Index
      AI 10.1 (Spring 2002) 
      AI Home
      | Magazine
      Choice
      | Topics
      | AI Store | Contact us 
 
      Other Web sites
      created by Azerbaijan International  
      AZgallery.org | AZERI.org | HAJIBEYOV.com
    
  |